Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections

1 - 25 of 49 Items

Letter to the Editor2023, nov 29

Incidence of lymphoid malignancies in patients with lymphocytosis identified by general practitioners

Marika Kasahara, Kajetan Karaszewski, Maria Król, Mateusz Ziarkiewicz, Wiesław Wiktor Jędrzejczak

Vol 14 (2023): Continuous Publishing

Letter to the Editor

Hematology in Clinical Practice 2023;14:52-54.
Research paper2023, nov 29

Clinical and demographic characteristics of sickle cell disease in colombian children

Sara Maria Soto, Carlos Andres Portilla, Herney Andrés García-Perdomo

Vol 14 (2023): Continuous Publishing

Research paper

Hematology in Clinical Practice 2023;14:46-51.
Case report2023, nov 29

Ruxolitinib as a primary treatment for multiple myeloma in a patient with primary myelofibrosis? A case report and the review of the literature

Przemysław Zygmunciak, Justyna Iskrzak, Joanna Góra-Tybor, Ewa Lech-Marańda, Bartosz Puła

Vol 14 (2023): Continuous Publishing

Case report

Hematology in Clinical Practice 2023;14:41-45.
Research paper2023, nov 29

Oral iron absorption test: myth or reality?

Samet Yaman, Yağmur Kınacı Gümüşçubuk, Oğuzcan Gümüşçubuk, Berkan Karabuğa, Sema Akinci, İmdat Dilek

Vol 14 (2023): Continuous Publishing

Research paper

Hematology in Clinical Practice 2023;14:35-40.
Review paper2023, oct 2
Research paper2023, jun 15

Study of type and frequency of Alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran

Parvaneh Tavakoli Afshar, Zohreh Taherian, Negar Nouri, Erfan Zaker, Sara Asadi, Farzaneh Rami, Roya Bakhtiari, Majid Hosseinzadeh, Mansoor Salehi

Vol 14 (2023): Continuous Publishing

Research paper

Hematology in Clinical Practice 2023;14:24-29.
Case report2023, jun 15

Pulmonary embolism after anti-SARS-CoV-2 vaccines in two female patients

Katarzyna Korzeniowska, Artur Cieślewicz, Katarzyna Grabańska-Martyńska, Anna Flotyńska, Anna Jabłecka

Vol 14 (2023): Continuous Publishing

Case report

Hematology in Clinical Practice 2023;14:18-23.
Review paper2023, jun 15

Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies

Małgorzata Bobrowicz, Magdalena Góralska, Aleksandra Kusowska, Anna Skowrońska-Szcześniak, Tomasz Bednarczuk

Vol 14 (2023): Continuous Publishing

Review paper

Hematology in Clinical Practice 2023;14:11-17.
Review paper2023, apr 28

How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?

Aleksander Salomon-Perzyński, Bożena Katarzyna Budziszewska

Vol 14 (2023): Continuous Publishing

Review paper

Hematology in Clinical Practice 2023;14:6-10.
Case report2023, apr 28
Case report2023, feb 16

Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH

Joseph Alburqueque-Melgarejo, Juan Carlos Roque-Quezada, Javier Dulanto Moscoso, Emanuel Salcedo Davila, Brady Beltrán Gárate

Vol 13, No 3-4 (2022)

Case report

Hematology in Clinical Practice 2022;13(3-4):123-129.
Review paper2023, feb 16

Therapeutic options in high-risk myelodysplastic syndrome

Marcela Maksymowicz, Sara Moqbil, Piotr Machowiec, Monika Podhorecka

Vol 13, No 3-4 (2022)

Review paper

Hematology in Clinical Practice 2022;13(3-4):97-111.
Review paper2023, feb 16

Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy

Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel, Grzegorz Helbig, Tomasz Wróbel, Jan Maciej Zaucha, Bożena Budziszewska, Agnieszka Wierzbowska

Vol 13, No 3-4 (2022)

Review paper

Hematology in Clinical Practice 2022;13(3-4):112-122.
Review paper2023, feb 12

Waldenström macroglobulinemia: diagnosis and treatment

Krzysztof Giannopoulos

Vol 13, No 3-4 (2022)

Review paper

Hematology in Clinical Practice 2022;13(3-4):89-96.
Guidelines / Expert consensus2023, jan 31

Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients

Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski

Vol 13, No 3-4 (2022)

Guidelines / Expert consensus

Hematology in Clinical Practice 2022;13(3-4):81-88.
Case report2023, jan 13

Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness

Daria Majowicz, Konrad Kostrzewa, Tomasz Gromek, Bożena Sokołowska, Marek Hus

Vol 13, No 3-4 (2022)

Case report

Hematology in Clinical Practice 2022;13(3-4):130-137.
Case report2022, oct 20

Eosinophilia caused by Toxocara canis infection

Monika Kowalik, Aleksandra Gołos, Joanna Góra-Tybor

Vol 13, No 2 (2022)

Case report

Hematology in Clinical Practice 2022;13(2):62-68.
Review paper2022, oct 20

Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland

Krzysztof Giannopoulos, Krzysztof Jamroziak, Tomasz Wróbel, Dominik Dytfeld

Vol 13, No 2 (2022)

Review paper

Hematology in Clinical Practice 2022;13(2):41-48.
Case report2022, oct 20

Oral manifestations of leukaemia: cooperation between dentist and haematologist

Ewa Michalak, Agata Dudzik, Joanna Śręba, Barbara Kęsek, Dagmara Darczuk

Vol 13, No 2 (2022)

Case report

Hematology in Clinical Practice 2022;13(2):55-61.
Review paper2022, oct 20

Diagnosis and treatment of immune thrombocytopenia in Poland

Piotr Małecki, Sebastian Grosicki

Vol 13, No 2 (2022)

Review paper

Hematology in Clinical Practice 2022;13(2):49-54.
Case report2022, oct 20

Midostaurin added to standard therapy in FLT3-positive acute myeloid leukaemia treatment

Andrzej Szczepaniak, Zuzanna Rzetelska

Vol 13, No 2 (2022)

Case report

Hematology in Clinical Practice 2022;13(2):69-74.
Case report2022, may 21

Burkitt-like lymphoma with 11q aberration mimicking appendicitis in a young man — a diagnostic and therapeutic challenge

Ryszard Swoboda, Karolina Gajda, Roman Lamch, Sebastian Giebel

Vol 13, No 2 (2022)

Case report

Hematology in Clinical Practice 2022;13(2):75-79.
Review paper2022, may 20

IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia

Bartosz Puła, Krzysztof Jamroziak, Tomasz Wróbel, Krzysztof Giannopoulos, Iwona Hus

Vol 13, No 1 (2022)

Review paper

Hematology in Clinical Practice 2022;13(1):7-14.
Review paper2022, may 9

Hematological manifestations of X-linked lymphoproliferative disease

Natalia Aleksandra Dułak, Jadwiga Juwa, Rafał Trzciński, Alan Majeranowski, Ninela Irga-Jaworska

Vol 13, No 1 (2022)

Review paper

Hematology in Clinical Practice 2022;13(1):1-6.
Case report2022, may 9

Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine

Katarzyna Korzeniowska, Artur Cieślewicz, Anna Flotyńska, Anna Jabłecka

Vol 13, No 1 (2022)

Case report

Hematology in Clinical Practice 2022;13(1).



Hematology in Clinical Practice